A Win For Kala Pharmaceuticals, Inc.
Fri, Dec 30, 2022 at 07:06 PM
Kala Pharmaceuticals, Inc. (KALA:NASDAQ) soared at $38.15, representing a gain of 53.6%. On Fri, Dec 30, 2022, KALA:NASDAQ hit a New 2-Week High of $38.15. The stock got featured on our News Catalysts scanner on Fri, Dec 30, 2022 at 02:14 PM in the 'BIOTECH' category. From Fri, Dec 16, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Kala Pharmaceuticals, Inc. (KALA:NASDAQ)
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
- SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
- Palisade Bio Inc. (PALI:NASDAQ), 61.49%
- F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%